Literature DB >> 1930571

Some unusual members of the family Pasteurellaceae isolated from human sources--phenotypic features and genomic relationships.

F Eckert1, A Stenzel, R Mutters, W Frederiksen, W Mannheim.   

Abstract

Twelve human isolates exhibiting the properties of the family Pasteurellaceae but phenotypically deviating from established species, or resembling species of animal origin that are only rarely reported to occur in human materials, were checked for their identities by DNA-DNA hybridization. The collection consisted of one strain of Actinobacillus lignieresii, two strains of Actinobacillus hominis (mannose-positive), two hitherto undescribed Actinobacillus or Actinobacillus-like species, [Pasteurella] haemolytica biovar T, CDC group HB-5 (initially oxidase and indole-negative), a new species in the [Haemophilus] aphrophilus [Haemophilus] segnis group, a new sucrose-negative and gas-producing Pasteurella-like species, and three strains of Bisgaard's Pasteurella-like taxon 16. Some diagnostically useful features of these unusual human Pasteurellaceae are described.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1930571     DOI: 10.1016/s0934-8840(11)80061-7

Source DB:  PubMed          Journal:  Zentralbl Bakteriol        ISSN: 0934-8840


  3 in total

1.  Actinobacillus hominis as a causative agent of septicemia in hepatic failure.

Authors:  J Wüst; J Gubler; W Mannheim; A von Graevenitz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-08       Impact factor: 3.267

2.  Clinical significance and taxonomy of Actinobacillus hominis.

Authors:  A Friis-Møller; J J Christensen; V Fussing; A Hesselbjerg; J Christiansen; B Bruun
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

3.  Characterization of sucrose-negative Pasteurella multocida variants, including isolates from large-cat bite wounds.

Authors:  Henrik Christensen; Magne Bisgaard; Oystein Angen; Wilhelm Frederiksen; John Elmerdahl Olsen
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.